GENERAL INFORMATION AND OTHER FINANCIAL DATA - EARNINGS PER COMMON SHARE (Details) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended	3 Months Ended		9 Months Ended
	Jan. 31, 2022	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Earnings (losses) attributable to common shares		$ 485	$ (648)	$ 1,656	$ 650
Earnings (losses) attributable to common shares		$ 485	$ (648)	$ 1,656	$ 650
Weighted-average common shares outstanding for basic EPS (in shares)		314,724,000	319,144,000	315,301,000	309,350,000
Dilutive effect of stock options and RSUs (in shares)		1,363,000	0	1,156,000	797,000
Dilutive effect of mandatory convertible preferred stock (in shares)		0	0	0	707,000
Weighted-average common shares outstanding for diluted EPS (in shares)		316,087,000	319,144,000	316,457,000	310,854,000
Earnings per share, basic (dollars per share)		$ 1.54	$ (2.03)	$ 5.25	$ 2.10
Earnings per share, diluted (in dollars per share)		$ 1.53	$ (2.03)	$ 5.23	$ 2.09
Vested RSUs included in basic WASO (in shares)		401,000	451,000	402,000	453,000
Stock options, RSAs and RSUs
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Non-qualified stock options granted (in shares)	219,898
Performance-based RSUs
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Equity awards, granted (in shares)	338,080
Service-based RSUs
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Equity awards, granted (in shares)	150,286
Stock options, RSAs and RSUs
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Antidilutive securities excluded from earnings per share (in shares)		0	147,840	115,376	240,654
Convertible Preferred Stock
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Antidilutive securities excluded from earnings per share (in shares)			639,733		3,037,812
Stock Options and Restricted Stock Units
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Antidilutive securities excluded from earnings per share (in shares)			699